Bayani
Matsakaicin mu na tofacitinib kuma ana san shi da cis-1-benzyl-4-methyl-3-methylaminopperidine dihydrochloride kuma yana da lambar CAS 1062580-52-2.Matsakaicin sinadari ne mai mahimmanci a cikin samar da tofacitinib, maganin da ake amfani da shi don magance cututtukan cututtuka na rheumatoid, psoriatic arthritis da ulcerative colitis.A matsayin maɓalli masu mahimmanci a cikin haɗin tofacitinib, samfuranmu suna da mahimmanci ga masu binciken magunguna da masana'antun.
Wannan tsaka-tsakin tsaka-tsakin an haɗa shi a hankali don tabbatar da mafi girman matakin tsabta da daidaito.Tare da tsarin masana'antunmu na zamani da tsauraran matakan kulawa, za ku iya amincewa da cewa masu tsaka-tsakin mu na tofacitinib sun hadu da mafi girman matakan masana'antu don tsabta da kwanciyar hankali.
Tofacitinib Intermediate (3R, 4R) -1-Benzyl-3- (Mmethylamino) -4-Mmethylpiperidine DiHClide yana da nau'i-nau'i na aikace-aikace, yana sa ya zama mahimmanci a cikin bincike na magunguna da sinadarai.Ko kuna gudanar da bincike na ilimi ko haɓaka magunguna, tsaka-tsakin mahaɗan mu suna ba da amintattun mafita masu inganci ga takamaiman bukatunku.
Zaba Mu
JDK ya mallaki wuraren samar da ajin farko da na'urorin sarrafa inganci, wanda ke tabbatar da tsayayyen samar da matsakaicin API.Ƙwararrun ƙungiyar sun tabbatar da R&D na samfurin.A kan duka biyun, muna neman CMO & CDMO a cikin gida da kasuwannin duniya.
